Virpax Pharmaceuticals Inc (VRPX)
2.29
-0.25
(-9.84%)
USD |
NASDAQ |
May 02, 16:00
2.29
0.00 (0.00%)
After-Hours: 17:58
Virpax Pharmaceuticals Price to Book Value: 1.387 for May 2, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 01, 2024 | 1.538 |
| April 30, 2024 | 1.604 |
| April 29, 2024 | 1.677 |
| April 26, 2024 | 1.877 |
| April 25, 2024 | 1.767 |
| April 24, 2024 | 1.919 |
| April 23, 2024 | 1.913 |
| April 22, 2024 | 1.998 |
| April 19, 2024 | 2.228 |
| April 18, 2024 | 2.446 |
| April 17, 2024 | 2.101 |
| April 16, 2024 | 2.101 |
| April 15, 2024 | 2.138 |
| April 12, 2024 | 2.150 |
| April 11, 2024 | 2.186 |
| April 10, 2024 | 2.216 |
| April 09, 2024 | 2.125 |
| April 08, 2024 | 2.271 |
| April 05, 2024 | 2.355 |
| April 04, 2024 | 2.476 |
| April 03, 2024 | 2.519 |
| April 02, 2024 | 2.525 |
| April 01, 2024 | 2.549 |
| March 28, 2024 | 2.580 |
| March 27, 2024 | 2.283 |
| Date | Value |
|---|---|
| March 26, 2024 | 2.349 |
| March 25, 2024 | 2.304 |
| March 22, 2024 | 2.440 |
| March 21, 2024 | 2.507 |
| March 20, 2024 | 2.656 |
| March 19, 2024 | 2.528 |
| March 18, 2024 | 2.258 |
| March 15, 2024 | 2.524 |
| March 14, 2024 | 2.343 |
| March 13, 2024 | 2.128 |
| March 12, 2024 | 2.434 |
| March 11, 2024 | 2.997 |
| March 08, 2024 | 2.743 |
| March 07, 2024 | 2.561 |
| March 06, 2024 | 2.410 |
| March 05, 2024 | 2.604 |
| March 04, 2024 | 2.280 |
| March 01, 2024 | 2.125 |
| February 29, 2024 | 1.848 |
| February 28, 2024 | 1.922 |
| February 27, 2024 | 1.758 |
| February 26, 2024 | 2.058 |
| February 23, 2024 | 2.046 |
| February 22, 2024 | 1.878 |
| February 21, 2024 | 1.816 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3752
Minimum
Dec 30 2022
15.07
Maximum
Aug 18 2021
1.481
Average
0.7952
Median
Apr 01 2022
Price to Book Value Benchmarks
| Sorrento Therapeutics Inc | -- |
| Scilex Holding Co | -- |
| Coya Therapeutics Inc | 3.585 |
| CEL-SCI Corp | 6.315 |
| AIM ImmunoTech Inc | 2.109 |
Price to Book Value Related Metrics
| Price | 2.29 |
| Earnings Yield | -566.4% |
| Market Cap | 2.682M |